Article type
Abstract
Background: In recent years, the Brazilian Ministry of Health (MoH) has published increasingly national clinical practice guidelines, called clinical protocols and therapeutic guidelines (PCDT) and has invested in improving greater quality and reliability in its elaborations. Recently, 3 updates drafts have been submitted for public consultation and hereinafter they will be incorporated to guarantee the best healthcare in Brazilian context and with local resources available.
Objectives: To evaluate the methodological rigour and transparency of more recents PCDT drafts.
Methods: We intentionally selected three new PCDT’s drafts to be evaluated by two trained and independently reviewers using AGREE II instrument. Items with a score difference ≥ 2 points were discussed and resolved through consensus. Discrepancies were resolved by consensus between the 3 reviewers. A third reviewer was involved when needed. Overall CPG quality was classified as high, moderate and low with A to C grading (Figure 1).
Results: The three PCDT drafts and AGREE II scores are described in Table 1. All PCDT drafts scored lower than
Objectives: To evaluate the methodological rigour and transparency of more recents PCDT drafts.
Methods: We intentionally selected three new PCDT’s drafts to be evaluated by two trained and independently reviewers using AGREE II instrument. Items with a score difference ≥ 2 points were discussed and resolved through consensus. Discrepancies were resolved by consensus between the 3 reviewers. A third reviewer was involved when needed. Overall CPG quality was classified as high, moderate and low with A to C grading (Figure 1).
Results: The three PCDT drafts and AGREE II scores are described in Table 1. All PCDT drafts scored lower than